Anatomic Pathology Market To Reach $71.68 Billion By 2033

May 2026 | Report Format: Electronic (PDF)

Anatomic Pathology Market Growth & Trends

The global anatomic pathology market size is expected to reach USD 71.68 billion by 2033, registering a CAGR of 8.09% from 2026 to 2033, according to a new report by Grand View Research, Inc. The advent of technology in the instruments and the protocols used during the anatomic pathological procedures is anticipated to increase the adoption rate of advanced anatomic pathological instruments.

Market players are collaborating for the refurbishment of pathology products by the incorporation of innovative disease diagnostic models. In April 2021, Leica Biosystems collaborated with Paige, an AI-based diagnostics company, for expanded access to computational pathology products for translational and clinical research. Under this partnership, Paige’s AI-enabled research software and Leica Biosystems’ digital pathology platform were combined. This, in turn, accelerates investments in the up-gradation of pathological equipment.

Pathology-training programs offered to pathologist trainees by public and private entities drive the market. For instance, the Accreditation Council for Graduate Medical Education accredited residency programs for anatomic pathology provide education and training to individuals via numerous teaching conferences.

The drug discovery and development application segment are expected to witness the fastest growth over the forecast period due to the shifting paradigm from conventional medicine to personalized medicine. This is primarily due to the growing reliance on discoveries of putative biomarkers for the development of personalized therapies. Ongoing pathology training programs to ensure that the pathology residents are aware of the developments taking place in the field of personalized medicine have also accelerated the market growth.

North America held the largest revenue share in 2020 owing to a large number of funding programs by public agencies and the presence of key players. Asia Pacific is expected to witness the fastest growth due to the presence of multiple associations that are engaged in conducting pathology training programs.

Key players are undertaking various strategic initiatives such as mergers & acquisitions and new product development to maintain their market presence. For instance, in May 2021, CellCarta acquired Reveal Biosciences, an AI-based pathology firm. This acquisition is aimed at expanding CellCarta’s offerings in AI-enabled multi-omic data analysis services and applications.

key Request a free sample copy or view report summary: Anatomic Pathology Market Report

Anatomic Pathology Market Report Highlights

The accelerating adoption of digital pathology and AI-enabled diagnostic workflows is emerging as a major growth driver for the anatomic pathology industry.
The anatomic pathology industry is currently experiencing significant innovation, driven primarily by advances in digital pathology, artificial intelligence (AI), and molecular diagnostics.
The reagents & consumables segment led the market with the largest revenue share of 48.87% in 2025, because of its critical and recurring role in diagnostic workflows.
The histopathology segment accounted for the largest market revenue share in 2025, driven by the rising global incidence of cancer and other chronic diseases that require detailed tissue-based diagnosis
The disease diagnosis segment led the market with the largest revenue share of 76.14% in 2025, owing to the growing global burden of chronic diseases, cancer prevalence, and increased demand for early and precise diagnostic testing.
The hospitals segment led the market with the largest revenue share of 37.29% in 2025, driven by high patient footfall, comprehensive diagnostic infrastructure, and the integration of multidisciplinary services.
North America dominated the global anatomic pathology market with the largest revenue share of 38.84% in 2025, owing to several key factors.

Anatomic Pathology Market Segmentation

Grand View Research has segmented the global anatomic pathology market report based on product & service, application, end use, and region:

Anatomic Pathology Product & Service Outlook (Revenue, USD Billion, 2021 - 2033)

Instruments
- Microtomes & Cryostat
- Tissue Processors
- Automatic Stainers
- Whole Slide Imaging (WSI) Scanners
- Other Products
Consumables
- Reagents & Antibodies
- Probes & Kits
- Others
Services